<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00856102</url>
  </required_header>
  <id_info>
    <org_study_id>H2008:318</org_study_id>
    <nct_id>NCT00856102</nct_id>
  </id_info>
  <brief_title>Exercise and Cognitive-psychosocial Functions in Men With Prostate Cancer Receiving Androgen Depletion Therapy</brief_title>
  <official_title>Efficacy of Exercise in Promotion Cognitive-psychosocial Functions in Men With Prostate Cancer Receiving Androgen Depletion Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Health Sciences Centre Foundation, Manitoba</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the proposed research is to determine the efficacy of a home-based walking&#xD;
      exercise program in promoting cognitive-psychosocial functions of men with prostate cancer&#xD;
      receiving androgen depletion therapy (ADT). ADT is the mainstay treatment for men with&#xD;
      advanced prostate cancer. However, ADT has a number of side effects including compromised&#xD;
      cognitive function, depression and anxiety, which negatively impacts the quality of life of&#xD;
      men with prostate cancer. The central question of the proposed research is to determine if&#xD;
      exercise will have a positive impact on the quality of life of men with prostate cancer&#xD;
      undergoing ADT.&#xD;
&#xD;
      Hypothesis:&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cognitive-psychosocial functions</measure>
    <time_frame>3 and 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>health-related quality of life</measure>
    <time_frame>3 and 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Home-base walking program</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Usual care</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  men aged 50 or older&#xD;
&#xD;
          -  diagnosed with adenocarcinoma prostate cancer&#xD;
&#xD;
          -  will initiate and receive continuous ADT (LHRH or combination of LHRH and&#xD;
             anti-androgen for at least 6 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  severe cardiac disease (New York Heart Association class III or greater)&#xD;
&#xD;
          -  angina&#xD;
&#xD;
          -  severe osteoporosis&#xD;
&#xD;
          -  uncontrolled hypertension&#xD;
&#xD;
          -  orthostastic blood pressure drop &gt; 20mm Hg&#xD;
&#xD;
          -  moderate to severe aortic stenosis&#xD;
&#xD;
          -  acute illness or fever&#xD;
&#xD;
          -  uncontrolled atrial or ventricular dysrhythmias&#xD;
&#xD;
          -  uncontrolled sinus tachycardia (&gt; 120 beats per minute)&#xD;
&#xD;
          -  uncontrolled congestive heart failure&#xD;
&#xD;
          -  third-degree atrio-ventricular heart block&#xD;
&#xD;
          -  active pericarditis or myocarditis&#xD;
&#xD;
          -  recent embolism, thrombophlebitis&#xD;
&#xD;
          -  deep vein thrombosis, resting ST displacement&#xD;
&#xD;
          -  uncontrolled diabetes&#xD;
&#xD;
          -  uncontrolled pain&#xD;
&#xD;
          -  cognitive impairment&#xD;
&#xD;
          -  history of falls due to balance impairment or lost of consciousness&#xD;
&#xD;
          -  severe neuromusculoskeletal conditions that limit their ability to perform walking&#xD;
             exercise&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 0T6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <study_first_submitted>March 3, 2009</study_first_submitted>
  <study_first_submitted_qc>March 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2009</study_first_posted>
  <last_update_submitted>January 31, 2011</last_update_submitted>
  <last_update_submitted_qc>January 31, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2011</last_update_posted>
  <responsible_party>
    <name_title>C. Ellen Lee,</name_title>
    <organization>University of Manitoba</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

